Sd. Stroop et al., DETERMINANTS FOR CALCITONIN ANALOG INTERACTION WITH THE CALCITONIN RECEPTOR N-TERMINUS AND TRANSMEMBRANE-LOOP REGIONS, Endocrinology, 137(11), 1996, pp. 4752-4756
High affinity binding was characterized for a number of salmon calcito
nin (sCT) analogs to a chimeric receptor (NtCTr) constructed by splici
ng the N-terminal domain of the human CT receptor onto the C-terminal,
transmembrane loop region of the receptor for glucagon. Another chime
ric receptor (NtGGr) with the N-terminal domain of the glucagon recept
or spliced onto the C-terminal regions of the CT receptor shows no hig
h affinity binding of sCT. Nevertheless, sCT and a number of analogs o
f the hormone are able to elevate cAMP levels in cells transfected wit
h NtGGr. The least helical analog, des-1-amino-[Ala(1,7),Gly(8)]des-Le
u(19)-sCT, is one of the most active in this regard. Two hormone analo
gs with modifications in the amino-terminal region, des-Ser(2)-sCT and
[Gly(2,3,4,5,6)]sCT, show reduced or no activity, respectively, for e
levating cAMP in cells expressing the NtGGr. In addition, a 15-fold ex
cess of the peptide sCT-(8-32) antagonizes sCT activation of this rece
ptor. In contrast, these calcitonin analogs exhibited a different rank
order for binding to the NtCTr receptor. In fact, des-Ser(2)-sCT and
[Gly(8)]-des-Leu(19)-sCT along with the native hormone had the highest
helical content as well as the highest binding affinities to the NtCT
r receptor. These studies suggest that the helical portion of the horm
one within residues 8-22 of sCT is the principal determinant for bindi
ng to the receptor N-terminus. Residues 2-6 of sCT interact with the r
eceptor transmembrane loop region and are critical for activation of a
denylate cyclase; however, residues 8-32, including Leu(16), are respo
nsible for most of the hormone interaction with the transmembrane loop
region. Thus, unique requirements exist for CT interaction at the rec
eptor N-terminus relative to the receptor transmembrane loop region, y
et there is significant overlap in the hormone determinants that facil
itate these interactions.